ACO5.F News Today: Stay Updated with the Latest Atlas Copco AB (publ) News in Real Time
Find ACO5.F news now at Meyka AI. Stay informed with the latest Atlas Copco AB (publ) stocks updates, including price news, market analysis, and expert insights.
Apollo and Blackstone Commit $35 Billion to Anthropic’s AI Infrastructure
Apollo Global Management and Blackstone have finalized a $35 billion financing package for Anthropic, marking one of the largest private credit transactions in AI history. The funding will help Anthropic secure advanced AI computing infrastructure, primarily through Google’s custom Tensor Processing Units, known as TPUs, which are essential for training and running large language models…
LBGUF Earnings Beat: L E Lundbergföretagen Q2 2026 Results
LBGUF reported Q2 2026 earnings on May 21, 2026 with $2.02 EPS and $868.45M revenue. Meyka AI rates the stock B+.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD on PNK. Medical device company faces high valuation multiples despite strong 6-month gains of 40%.
BRCTF Earnings Beat: BioArctic AB (publ) Crushes Q2 2026 Estimates
BioArctic AB (BRCTF) beat Q2 2026 earnings on May 20 with EPS of $0.2514 vs. -$0.0316 estimate and $46.04M revenue vs. $20.26M expected.
NDRBF Earnings Beat: NIBE Industrier Q2 2026 Results
NDRBF beats EPS and revenue estimates in Q2 2026 earnings. NIBE Industrier reports $0.0263 EPS vs $0.0257 estimate, $1.02B revenue.
Genocea Biosciences Stock Collapses 97% as Bankruptcy Restructuring Continues
GNCA stock plummets 97.44% to $0.0001 after Chapter 11 bankruptcy filing. Biotech firm restructures cancer immunotherapy pipeline.
Beyond Frames Entertainment Stock Slips 1.9% Ahead of Earnings
8WP.F stock drops 1.9% to €0.207 on XETRA ahead of May 21 earnings announcement. Gaming firm faces profitability challenges.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD. Medical device maker faces elevated valuation metrics and mixed analyst outlook in healthcare sector.
BioArctic AB (BRCTF) Earnings Preview: EPS Seen at -$0.0316 on Q2 2026
BRCTF earnings preview: BioArctic AB (publ) reports May 20, 2026. EPS estimate -$0.0316, revenue $20.26M. Analyst expectations and key metrics.